December 5, 2019

Cytiva to Expand KUBio Through Close Collaboration with Pharmadule Morimatsu


Cytiva has announced it will be working closely with Pharmadule Morimatsu to expand its KUBio “factory in a box” so that biopharma manufacturers will be able to quickly scale up vaccines, viral vector-based therapies, and other novel modalities.

Click here to read more.

Tags: viral vector, vaccines, scale-up